HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neil H Shear Selected Research

Phototherapy (Light Therapy)

3/2019Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.
7/2014Childhood mycosis fungoides: experience of 28 patients and response to phototherapy.
8/2012A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.
12/2009Efficacy outcomes in patients using alefacept in the AWARE study.
12/2009Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study.
9/2004Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Neil H Shear Research Topics

Disease

26Psoriasis (Pustulosis Palmaris et Plantaris)
11/2023 - 06/2003
16Hypersensitivity (Allergy)
01/2021 - 11/2002
8Onychomycosis (Tinea Unguium)
05/2022 - 01/2008
8Infections
03/2021 - 01/2006
8Drug-Related Side Effects and Adverse Reactions
03/2018 - 12/2002
7Exanthema (Rash)
01/2021 - 06/2003
6Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2022 - 07/2005
6Atopic Dermatitis (Atopic Eczema)
12/2021 - 01/2004
6Pemphigus (Pemphigus Vulgaris)
05/2017 - 06/2012
4Neoplasms (Cancer)
01/2023 - 06/2002
4Fever (Fevers)
04/2019 - 06/2003
4Necrosis
03/2019 - 01/2002
4Skin Diseases (Skin Disease)
10/2016 - 06/2003
3Alopecia (Baldness)
11/2019 - 01/2019
3Burns
03/2019 - 11/2006
3Hepatitis C
09/2014 - 01/2002
3Inflammation (Inflammations)
01/2006 - 01/2002
2Pain (Aches)
06/2022 - 10/2016
2Bacterial Infections (Bacterial Infection)
12/2021 - 06/2003
2Dermatitis
05/2021 - 06/2011
2Drug Eruptions (Drug Eruption)
01/2021 - 01/2009
2Tuberculosis (Tuberculoses)
01/2021 - 01/2006
2Melanoma (Melanoma, Malignant)
05/2020 - 05/2017
2Vitiligo
01/2020 - 09/2003
2Drug Hypersensitivity Syndrome
09/2019 - 06/2003
2Acne Vulgaris
03/2019 - 04/2013
2Cicatrix (Scar)
03/2019 - 11/2006
2Nausea
09/2018 - 09/2005
2Eosinophilia
01/2018 - 01/2009
2Hidradenitis Suppurativa
05/2017 - 11/2015
2Bullous Pemphigoid (Pemphigoid)
05/2015 - 08/2013
2Hepatitis
09/2014 - 01/2003
2Rheumatoid Arthritis
07/2014 - 01/2006
2Acute Generalized Exanthematous Pustulosis
04/2014 - 03/2003
2Urticaria (Hives)
07/2007 - 01/2003
2Fibrosis (Cirrhosis)
06/2002 - 01/2002
2Chronic Hepatitis C
06/2002 - 01/2002
1Phobic Disorders (Phobia)
08/2022
1Abscess
06/2022
1Genetic Predisposition to Disease (Genetic Predisposition)
04/2022
1COVID-19 related pediatric multisystem inflammatory disease
01/2022
1COVID-19
01/2022
1Invasive Fungal Infections
12/2021
1Prurigo
10/2021
1Alopecia Areata
09/2021

Drug/Important Bio-Agent (IBA)

7Antifungal AgentsIBA
05/2022 - 11/2017
6Etanercept (Enbrel)FDA Link
01/2022 - 01/2006
6Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 12/2002
6Anticonvulsants (Antiepileptic Drugs)IBA
04/2019 - 06/2003
6Alefacept (Amevive)FDA Link
08/2012 - 01/2006
5Methotrexate (Mexate)FDA LinkGeneric
09/2021 - 01/2006
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2002
5Adrenal Cortex Hormones (Corticosteroids)IBA
11/2019 - 06/2011
5SulfonamidesIBA
09/2019 - 12/2002
5Rituximab (Mabthera)FDA Link
05/2015 - 06/2012
4Infliximab (Remicade)FDA Link
06/2022 - 01/2006
4Terbinafine (Lamisil)FDA LinkGeneric
05/2022 - 01/2020
4apremilastIBA
04/2020 - 01/2018
4InterleukinsIBA
03/2019 - 12/2008
4Monoclonal AntibodiesIBA
03/2019 - 12/2008
4Ustekinumab (CNTO 1275)FDA Link
12/2018 - 12/2008
3Clindamycin (Cleocin)FDA LinkGeneric
06/2022 - 03/2003
3efinaconazoleIBA
05/2022 - 11/2017
3SolutionsIBA
05/2022 - 11/2006
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2022 - 09/2006
3Tacrolimus (Prograf)FDA LinkGeneric
09/2019 - 01/2004
3abacavir (Ziagen)FDA Link
01/2019 - 11/2002
3Carbamazepine (Tegretol)FDA LinkGeneric
01/2019 - 09/2012
3Adalimumab (Humira)FDA Link
12/2018 - 01/2006
3CytokinesIBA
05/2007 - 01/2002
2Fluconazole (Zonal)FDA LinkGeneric
05/2022 - 01/2020
2Itraconazole (Sporanox)FDA LinkGeneric
05/2022 - 01/2020
2tavaboroleIBA
05/2022 - 11/2017
2dupilumabIBA
10/2021 - 10/2021
2Immunoglobulin E (IgE)IBA
01/2021 - 09/2019
2AntigensIBA
01/2021 - 09/2003
2Calcineurin InhibitorsIBA
09/2019 - 01/2004
2pimecrolimus (Elidel)FDA Link
09/2019 - 01/2004
2EnzymesIBA
04/2019 - 07/2007
2Interleukin-12 (IL 12)IBA
03/2019 - 12/2008
2HLA-B Antigens (HLA-B)IBA
01/2019 - 04/2014
2Isotretinoin (Accutane)FDA LinkGeneric
02/2018 - 04/2013
2Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
01/2013 - 09/2005
2efalizumab (Raptiva)FDA Link
01/2006 - 01/2006
2Transforming Growth Factor beta (TGF-beta)IBA
06/2002 - 01/2002
2Ribavirin (Virazole)FDA LinkGeneric
06/2002 - 01/2002
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2022
1Tetracycline (Achromycin)FDA LinkGeneric
06/2022
1bermekimabIBA
06/2022
1Ciclopirox (Loprox)FDA LinkGeneric
05/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
04/2022
1BNT162 VaccineIBA
01/2022

Therapy/Procedure

35Therapeutics
11/2023 - 01/2002
6Phototherapy (Light Therapy)
03/2019 - 09/2004
3Biological Therapy
12/2021 - 12/2009
2Drug Therapy (Chemotherapy)
01/2023 - 06/2003
2Lasers (Laser)
11/2019 - 11/2017
2Injections
03/2019 - 05/2011
1Immunotherapy
01/2023
1Palliative Care (Palliative Therapy)
01/2023